Advisory Committees
Transmissible Spongiform Encephalopathies Advisory Committee
The Transmissible Spongiform Encephalopathies Advisory Committee (TSEAC) reviews and evaluates available scientific data concerning the safety of products which may be at risk for transmission of spongiform encephalopathies having an impact on the public health as determined by the Commissioner of Food and Drugs.
The Committee shall consist of a core of 15 voting members, including the Chair. Members and the Chair are selected by the Commissioner or designee from among authorities knowledgeable in the fields of clinical and administrative medicine, hematology, virology, neurovirology, neurology, infectious diseases, immunology, transfusion medicine, surgery, internal medicine, biochemistry, biostatistics, epidemiology, biological and physical sciences, sociology/ethics, and other related professions.
Additional Information
Roster of the Transmissible Spongiform Encephalopathies Advisory Committee Charter of the Transmissible Spongiform Encephalopathies Advisory Committee 2011 Meeting Materials, Transmissible Spongiform Encephalopthies Advisory Commitee 2010 Meeting Materials, Transmissible Spongiform Encephalopathies Advisory Committee 2009 Meeting Materials, Transmissible Spongiform Encephalopathies Advisory Committee
Contact FDA
Division of Communication and Consumer Affairs
Office of Communication, Outreach and Development
Food and Drug Administration
1401 Rockville Pike
Suite 200N/HFM-47
Rockville, MD 20852-1448